Treatment Delays May Be Less Important Than Family Support

Treatment Delays May Be Less Important Than Family Support

312072

Treatment Delays May Be Less Important Than Family Support

The COVID-19 pandemic led to delays in treatment with Spinraza (nusinersen) for many children with spinal muscular atrophy (SMA). However, these delays seem to have a lower impact on children’s functional skills when compared with family support, according to a small study in Italy. The study, “Effect of the COVID-19 Pandemic on Children With SMA Receiving Nusinersen: What Is Missed and What Is Gained?,” was published in Frontiers in Neurology. Spinraza, marketed by Biogen, is the first…

You must be logged in to read/download the full post.